Css LLC Reata Pharmaceuticals Inc Put Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$20.71 - $36.5 $126,331 - $222,650
-6,100 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$24.12 - $39.6 $147,132 - $241,560
6,100 New
6,100 $200,000
Q4 2021

Feb 14, 2022
SELL
$25.61 - $110.96 $517,322 - $2.24 Million
-20,200 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$100.0 - $143.02 $2.02 Million - $2.89 Million
20,200 New
20,200 $2.03 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email